Skip to main content

Cabot Corporation (CBT) Stock Analysis

Breakout setup

SellVALUE-TRAP 1/5Moderate Confidence

Basic Materials · Specialty Chemicals

Earnings in 5 days (2026-05-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Analyst target reached at $76.47 — A.R:R is negative (-2.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: Dow chlorosilane feedstock.

Cabot Corporation is a global specialty chemicals company with two segments: Reinforcement Materials (carbon black for tires and industrial products) and Performance Chemicals (fumed metal oxides, aerogel, carbon nanotubes, inkjet colorants). Manufacturing spans the US and 20+... Read more

$76.47+0.5% A.UpsideScore 5.2/10#13 of 36 Specialty Chemicals
Stop $72.84Target $76.89(resistance)A.R:R -2.2:1
Analyst target$77.80+1.7%5 analysts
$76.89our TP
$76.47price
$77.80mean
$68
$85

Sell if holding. Analyst target reached at $76.47 — A.R:R is negative (-2.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: Dow chlorosilane feedstock. Chart setup: Golden cross, above all MAs, RSI 61, MACD bullish. Score 5.2/10, moderate confidence.

Passes 4/7 gates (clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 5d<=7d. Suitability: aggressive.

Thesis

Rewards
Strong earnings beat streak (4/4)
Attractive valuation
Risks
Concentration risk — Supplier: Dow chlorosilane feedstock
Analyst target reached - limited upside remaining
Earnings in 5 days (event risk)

Key Metrics

P/E (TTM)13.2
P/E (Fwd)11.0
Mkt Cap$4.0B
EV/EBITDA6.6
Profit Mgn8.6%
ROE21.8%
Rev Growth-11.1%
Beta0.83
Dividend2.38%
Rating analysts12

Quality Signals

Piotroski F7/9

Options Flow

P/C0.28bullish
IV52%elevated

Concentration Risks(10-K Item 1A)

  • MEDIUMGeographicChina25%
    10-K Item 1A: 'sales in China constituted approximately 25% of our revenues in fiscal 2025'
  • HIGHSupplierDow chlorosilane feedstock
    10-K Item 1A: 'Dow, our fence-line partner at our fumed metal oxides facility in Barry, Wales, announced that it would be ceasing its polysiloxane operations'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Revenue shrinking — -11.1% YoY. Growth thesis broken unless recovery story develops.static

Revenue Growth
0.0
Earnings Growth
6.0
Declining revenue: -11%
GatesMomentum 4.3<4.5A.R:R -2.2=NEGATIVEEARNINGS PROXIMITY 5d<=7dInsider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
61 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $72.44Resistance $78.46

Price Targets

$73
$77
A.Upside+0.5%
A.R:R-2.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Target reached (-11.5% upside)
! Momentum score 4.3/10 — below 4.5 minimum
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-05-05 (5d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CBT stock a buy right now?

Sell if holding. Analyst target reached at $76.47 — A.R:R is negative (-2.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: Dow chlorosilane feedstock. Chart setup: Golden cross, above all MAs, RSI 61, MACD bullish. Prior stop was $72.84. Score 5.2/10, moderate confidence.

What is the CBT stock price target?

Take-profit target: $76.89 (+0.5% upside). Prior stop was $72.84. Stop-loss: $72.84.

What are the risks of investing in CBT?

Concentration risk — Supplier: Dow chlorosilane feedstock; Analyst target reached - limited upside remaining; Earnings in 5 days (event risk).

Is CBT overvalued or undervalued?

Cabot Corporation trades at a P/E of 13.2 (forward 11.0). TrendMatrix value score: 7.8/10. Verdict: Sell.

What do analysts say about CBT?

12 analysts cover CBT with a consensus score of 2.6/5. Average price target: $78.

What does Cabot Corporation do?Cabot Corporation is a global specialty chemicals company with two segments: Reinforcement Materials (carbon black for...

Cabot Corporation is a global specialty chemicals company with two segments: Reinforcement Materials (carbon black for tires and industrial products) and Performance Chemicals (fumed metal oxides, aerogel, carbon nanotubes, inkjet colorants). Manufacturing spans the US and 20+ other countries; sales in China constituted ~25% of fiscal 2025 revenues.

Related stocks: ECVT (Ecovyst Inc.) · SQM (Sociedad Quimica y Minera S.A.) · AXTA (Axalta Coating Systems Ltd.) · SCL (Stepan Company) · PRM (Perimeter Solutions, SA)